Family History and Cancer Risk Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,868

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Cancer-related Problem/ConditionFamily Characteristics
Interventions
BEHAVIORAL

MeTree Questionnaire

"MeTree is a patient driven risk assessment program with Clinical Decision Support (CDS) that enables collection of a three plus generation family health history (FHH) on 128 conditions. CDS is provided in a report with a pedigree and tailored evidence-based guidelines. While patient drive, MeTree also includes a provider-facing report with additional references. These reports promote engagement by both patients and providers and enhance shared decision-making.~MeTree first generates information imported from the participant's EHR record. These data include basic demographic information, any recent lab results, and any listed diseases or conditions from the EHR. Next, MeTree gives the participant an opportunity to fill out a family history tree. The more information the participant provides on their own health and their family member's health, the better MeTree can provide recommendations from current literature."

Trial Locations (2)

37208

Meharry Medical College, Nashville

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University Medical Center

OTHER